Related Experiment Video
Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Biomarkers
Bery Mohammediyan1,2, Sylvia Villeneuve3,4,5, Béatriz Oliveira6,7
1Center for advanced research in sleep medicine, Research Center of the CIUSSS-NIM, Montreal, QC, Canada.
Background:
We investigated whether insomnia may be associated with changes in cognition over time among older adults at elevated risk of Alzheimer's disease (AD).
Methods:
We studied 348 dementia-free older adults (mean age: 65.74 ± 5.57; 72% female) from the PREVENT-AD cohort, all at elevated AD risk due to family history of AD. At baseline, a self-reported insomnia symptoms index was computed based on the Pittsburgh Sleep Quality Index (PSQI). The presence of insomnia symptoms was defined as sleep onset latency >30min ≥3 times/week OR sleep maintenance is difficult ≥3 times/week AND these sleep disturbances interfere with daily life. A subsample of 240 participants also underwent objective sleep assessments (7-day actigraphy). Difficulty with sleep maintenance on actigraphy was defined as ≥3 times/week with a wake after sleep onset >60min or a sleep efficiency <78% (1.5 SD of sample). Cognition was assessed both at baseline and yearly for a total follow-up of 7.15 years on average (SD: 2.40 years), and included measures of immediate and delayed memory, attention, and total score on the Repeatable Battery for Assessment of Cognitive Status (RBANS). First, baseline and longitudinal cognition scores were compared between 3 groups stratified for self-reported insomnia symptoms severity (i.e., 0, ≤1 and 2+ symptoms) using ANCOVAs. The same analyses were performed between 3 groups stratified for objectively defined insomnia symptoms. Finally, cognition scores were compared between 4 groups stratified by the severity of both self-reported and objective insomnia symptoms (i.e., no symptoms, only self-reported symptoms, only objective symptoms or both self-reported and objective symptoms).
Results:
Individuals with ≥2 self-reported insomnia symptoms had higher baseline immediate and delayed memory scores than individuals with ≤1 insomnia symptoms (p = 0.02, Figure 1A; p = 0.02, Figure 1B). Actigraphy-indicating ≥2 insomnia symptoms had higher longitudinal delayed memory scores than individuals with ≤1 insomnia symptom (p = 0.02, Figure 1C). Individuals whose insomnia symptoms were observed only with actigraphy had the greatest longitudinal delayed memory scores (p = 0.01, Figure 1D).
Conclusion:
Counterintuitively, in individuals at elevated risk of AD, more self-reported and objective insomnia symptoms were associated with better cognitive scores. This may reflect protective lifestyle factors that improve cognition but also disrupt sleep patterns and sleep satisfaction.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

